Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Events » Peter MacCallum 25th Anniversary of PRRT with Professor Rod Hicks

Peter MacCallum 25th Anniversary of PRRT with Professor Rod Hicks

Register

NeuroEndocrine Cancer Australia and Peter MacCallum Cancer Centre invite you to celebrate:

25 years of Peptide Receptor Radionuclide Therapy (PRRT)

When:
Sunday, September 12, 2:00pm- 4:00pm

Where:
This is a virtual event. Please click the button below to join.

Have a question you would like to ask the MDT panel? Please click through to www.menti.com and use the code 7928 0034

Watch here

Agenda

2.00pmWelcomeProfessor Shelley Dolan (CEO, Peter MacCallum Cancer Centre)
2:05pmShort PresentationHon. Linda Dessau AC, Governor of Victoria
2:10pmNECA UpdateSimone Leyden (CEO, NeuroEndocrine Cancer Australia)
2:15pm25 Years of PRRTProfessor Rod Hicks (Peter MacCallum Cancer Centre)
2.30pmPatient StoryRoss Flanigan NET Patient
2:35pmShort Break 
2:40pmLatest Clinical Research/TrialsA/Prof Grace Kong (Peter MacCallum Cancer Centre)
3:05pmMock MDT Cases

Nuclear Medicine: Prof Rod Hicks and A/Prof Grace Kong

Oncologist: Prof Michael Michael

Endocrinologist: A/Prof Cherie Chiang

Pathologist: Dr Bill Murray

Surgeon: Dr Benjamin Loveday

Interventional and Diagnostic Radiologist : Dr Phil Chan

Nurse: Meg Rogers

PRRT Coordinator: Leah Neeson

3:35pmQ & A SessionLog in to www.menti.com with code 7928 0034 to ask questions
3:45pmTribute to serviceProfessor Rod Hicks
4:00pmCloseSimone Leyden

With thanks to:

The Speakers

Prof Rod Hicks

Peter MacCallum Cancer Centre

simone-headshot

Simone Leyden

Neuroendocrine Cancer Australia

Prof Michael Michael

Peter MacCallum Cancer Centre

Grace Kong

A/Prof Grace Kong

Peter MacCallum Cancer Centre

Nick Pavlakis Image

Prof Nick Pavlakis

Royal North Shore Hospital

Louise Emmett Image

Prof Louise Emmett

St Vincent's Hospital (Sydney)

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin